France· FR:66532840
YERVOY 5 mg/mL, solution à diluer pour perfusion
A medicinal product containing ipilimumab, registered in France by BRISTOL-MYERS SQUIBB / PFIZER EEIG (IRLANDE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- IPILIMUMAB
- Manufacturer
- BRISTOL-MYERS SQUIBB / PFIZER EEIG (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip133400958087707flacon(s) en verre de 10 ml
- cip133400958087875flacon(s) en verre de 40 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ipilimumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsYervoy 5mg/ml, concentraat voor oplossing voor infusieBristol-Myers Squibb Pharma EEIG
- United StatesYERVOYE.R. Squibb & Sons, L.L.C.
- United KingdomYervoy 200mg/40ml concentrate for solution for infusion vialsBristol-Myers Squibb Pharmaceuticals Ltd
- SpainYERVOY 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONBristol-Myers Squibb Pharma Eeig
- FinlandYERVOYOrifarm Oy
- BelgiumYervoy 5 mg/mlBristol-Myers Squibb Pharma
- SwitzerlandYERVOY 200 mg/40 ml, Konzentrat zur Herstellung einer InfusionslösungBristol-Myers Squibb SA
- CzechiaYERVOYBristol-Myers Squibb Pharma EEIG, Dublin
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Yervoy
- Liechtenstein · Yervoy
- Norway · Yervoy
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be48fe70-76db-47c5-b07b-8e5b65fe192e GET /v1/drugs/be48fe70-76db-47c5-b07b-8e5b65fe192e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66532840",
"date_amm": "2011-07-13",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/11/698",
"substance": "IPILIMUMAB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about ipilimumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.